Page 2 - Apollo Hospital Enterprises

VBL, MRPL among top picks of Anand Rathi for July 04; check key levels here

On an hourly scale, MRPL has been showing a consolidation pattern above the 21, 50, 100, and 200-period Exponential Moving Averages (EMA)

Major private hospital chains see rise in revenues per bed in FY24

They are on an expansion spree and guided for more bed additions in FY25

Hospital players enhance focus on cancer care amid a surge in cases

By 2025, cancer cases projected to hit 1.57 million, up 13% from 2020

Deal valuations weigh on Apollo Hospitals Enterprise, stock declines

Funds are to be utilised for growth capital in AHL, to pay for the Rs 890 cr of the Rs 1290 cr slump sale consideration owed to AHEL, and acquisition of an 11.2 per cent stake in Keimed for Rs 730 cr

Apollo Hospitals slips 8% on stake sale in AHL, Keimed merger

Apollo Hospitals Enterprises stock update: The stock hit its lowest level since January 10, 2024

Apollo Hospitals lines up Rs 3,000 crore investment post Advent deal

Advent and Apollo HealthCo have entered into a deal through which Advent will invest Rs 2,475 crore into Apollo HealthCo

'Significant technological investment needed for cancer treatment in India'

Sasidhar, the new president and chief executive officer of Apollo's hospital division, talks about future expansion, medical tourism, and growth roadmap

Significant growth in non-communicable diseases across India: Apollo report

A latest report on the health scenario in India on Friday indicated a significant growth in non-communicable diseases (NCDs) across the nation and said the country was witnessing fastest rise in cancer cases. On average, atleast one in three Indians today were pre-diabetic, two in three were pre-hypertensive and one in 10 were depressed, the 4th edition of Apollo Hospitals' flagship Health of Nation Report on World Health Day 2024, said. The report sheds light on the concerning rise of NCDs in India, including cancer, diabetes, hypertension, cardiovascular diseases, and mental health issues, all of which significantly impact the nation's overall health, the hospital said in a release here. Particularly alarming was the escalating incidence of cancer in India compared to global rates, making India the "cancer capital of the world," it said. The annual report predicted a potential surge in healthcare burdens due to conditions such as pre-diabetes, pre-hypertension, and mental health

Apollo Hospitals introduces ZAP-X radiosurgery platform for brain tumors

Traditional brain surgeries last three to four hours, ZAP-X completes treatment within a single session lasting no more than 30 minutes, John R Adler, founder and CEO of Zap Surgical said

As Covid-19 cases rise in India; should you keep pharma stocks on radar?

Barring Dr Lal Pathlabs, the other four healthcare related stocks listed below seem to be trapped in a range for now, charts suggest.

Cash-for-kidneys scam: Ministry orders inquiry against Apollo Hospitals

According to the Telegraph report, poor people from Myanmar "are being flown" to the Indraprastha Apollo Hospital in Delhi to sell "their kidneys to rich Burmese patients"

Apollo Hospitals posts July-Sept standalone profit after tax of Rs 295 cr

Apollo Hospitals Enterprise Ltd has recorded a standalone profit after tax of Rs 294.8 crore for the three months ended September 30, 2023, the healthcare major said on Friday. Apollo Hospitals reported a standalone profit after tax of Rs 279.1 crore during the corresponding quarter last year. For the half-year period ended September 30, 2023, the standalone profit after tax stood at Rs 508.9 crore, as against Rs 612.3 crore registered in the same period last year, the company said on Friday. Total income on a standalone basis during the quarter under review grew to Rs 1,931.1 crore from Rs 1,758.5 crore during the corresponding quarter of the previous year. For the six-month period ended September 30, 2023, the standalone total income grew to Rs 3,637.3 crore against Rs 3,298.7 crore registered in the same period last year. In a statement, Apollo Hospitals said the board, based on the recommendations of the investment committee, has evaluated and approved an expansion plan for th

Apollo Hospitals to raise $200 mn by selling 6% stake in online platform

In May, Apollo's fourth-quarter revenue from healthcare services climbed 18.5% and accounted for 51% of its total revenue

Stocks to watch: Adani Ports, NMDC, HDFC Life, Apollo Hospitals, PTC Inds

Stocks to watch on May 31, 2023: From Adani Ports to Sun Pharma, here are top stocks to watch in Wednesday's trading session

Apollo Hospitals Enterprise Q4 net profit rises 60% to Rs 145 crore

The company's consolidated revenue from operation rose by 21.3 per cent to Rs 4,302 crore for the March quarter as compared to Rs 3,546 crore in the year-ago period

Stocks to Watch: TCS, KPI Green, Siemens, Alstom India, Apollo Hospitals

Stocks to Watch Today: In the F&O space, BHEL, Delta Corp, Indiabulls Housing Finance and PNB are the stocks in ban period on Thursday.

Hospital chains abused their dominance to charge exorbitant prices: Report

A CCI investigation showed that higher pricing was charged for renting rooms, medicines, tests, medical devices, and consumables. In some hospitals, the room rents exceeded charges of 4-star hotels

Apollo Hospitals acquires asset from Nayati Healthcare for Rs 450 crore

The hospital asset was sold by DLF Qutub Enclave Complex Medical Charitable Trust in 2011 to Nayati Healthcare and Research NCR Pvt Ltd

Street looking beyond Apollo Hospitals' disappointing Q4 performance

Based on sum-of-the-parts valuation, some analysts have pegged their target price between Rs 4,900-5,000

Apollo Hospitals Q4 net profit falls 46% to Rs 90 cr; revenue jumps 24%

Apollo Hospitals Enterprises on Wednesday said its consolidated profit after tax declined by 46 per cent to Rs 90 crore for the fourth quarter ended on March 31, 2022. The health care provider had reported a PAT of Rs 168 crore in the January-March quarter of 2020-21 fiscal. Revenue from operations rose to Rs 3,546 crore in the fourth quarter as compared with Rs 2,868 crore in the year-ago period. For the full year ended March 31, 2022 the company posted a consolidated net profit of Rs 1,056 crore as against Rs 150 crore in the 2020-21 fiscal. Revenue from operations stood at Rs 14,663 crore for the last fiscal while the same was at Rs 10,560 crore in FY21. The company's board recommended a dividend of Rs 11.75 per share of face value of Rs 5 each for the financial year ended March 31, 2022, it added. The company said its board also approved the re-appointment of Prathap C Reddy as a whole time director designated as an Executive Chairman for a period of two years with effect fro